Equities

Little Green Pharma Ltd

LGP:ASX

Little Green Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.084
  • Today's Change0.003 / 3.70%
  • Shares traded122.69k
  • 1 Year change-47.50%
  • Beta1.5560
Data delayed at least 20 minutes, as of Sep 20 2024 06:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4.971220
Total Receivables, Net3.407.385.60
Total Inventory13108.19
Prepaid expenses0.580.420.58
Other current assets, total00.541.00
Total current assets213135
Property, plant & equipment, net616360
Goodwill, net------
Intangibles, net3.463.640.67
Long term investments0.040.040.04
Note receivable - long term0.320.390.20
Other long term assets------
Total assets869996
LIABILITIES
Accounts payable1.651.851.55
Accrued expenses0.881.471.65
Notes payable/short-term debt000
Current portion long-term debt/capital leases2.632.450.10
Other current liabilities, total1.265.2713
Total current liabilities6.421117
Total long term debt2.515.313.90
Total debt5.147.764.00
Deferred income tax------
Minority interest------
Other liabilities, total0.100.040.02
Total liabilities9.031620
SHAREHOLDERS EQUITY
Common stock10210190
Additional paid-in capital------
Retained earnings (accumulated deficit)(25)(19)(15)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity778275
Total liabilities & shareholders' equity869996
Total common shares outstanding300298240
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.